24/7 Market News Snapshot 14 March, 2025 – NanoVibronix, Inc. Common Stock (NASDAQ:NAOV)

March 14, 2025

DENVER, Colo., 14 March, 2025 (247marketnews.com) – (NASDAQ:NAOV) are discussed in this article.
NanoVibronix, Inc. (NASDAQ:NAOV) has seen significant movement in its stock performance, beginning the trading day at $1.94 before climbing 9.63% to a current price of $2.89. This notable increase highlights a rising confidence among investors, as indicated by a trading volume of 624.88K shares. Technical analysis reveals that NAOV may face resistance at the psychological threshold of $3, while support appears to be firmly established around the $2 mark. The robust trading volume accompanying the price climb suggests prospects for continued upward momentum, and close monitoring of key indicators such as the Relative Strength Index (RSI) and Moving Average Convergence Divergence (MACD) will be crucial for anticipating future price dynamics.

In another significant development, NanoVibronix has announced the positive outcomes of a comprehensive health service study published in The Australian and New Zealand Continence Journal, highlighting the efficacy of the UroShield® device in preventing catheter-associated urinary tract infections (CAUTIs). This independent study demonstrates that patients using UroShield experienced an astonishing 86% reduction in UTI incidences, complemented by a 70% decrease in catheter blockages and a remarkable 82.8% reduction in bladder irrigations performed. Furthermore, the research indicated a 52.3% decrease in the frequency of catheter changes, significantly enhancing patient comfort while reducing the burden on nursing staff.

Brian Murphy, CEO of NanoVibronix, articulated the importance of these findings, stating, “This study underscores the transformative potential of UroShield in enhancing patient care.” The results reveal a 63.5% decline in resource expenditures over a five-month project period, showcasing how UroShield not only improves patient outcomes but also fosters cost efficiency for healthcare providers. As NanoVibronix advances its mission to innovate in medical technology, the company remains committed to enhancing healthcare delivery systems and patient well-being.

Related news for (NAOV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.